Stocks and Investing
Stocks and Investing
Fri, May 12, 2023
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
[ Fri, May 12th 2023
] - WOPRAI
Mani Foroohar Downgraded (ARWR) to Hold and Held Target at $40 on, May 12th, 2023
Mani Foroohar of SVB Leerink, Downgraded "Arrowhead Pharmaceuticals, Inc." (ARWR) to Hold and Held Target at $40 on, May 12th, 2023.
Mani has made no other calls on ARWR in the last 4 months.
There are 10 other peers that have a rating on ARWR. Out of the 10 peers that are also analyzing ARWR, 2 agree with Mani's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $40 on, Wednesday, May 3rd, 2023
- William Pickering of "Bernstein" Initiated at Hold and Held Target at $27 on, Tuesday, March 21st, 2023
These are the ratings of the 8 analyists that currently disagree with Mani
- Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $60 on, Wednesday, May 3rd, 2023
- Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $73 on, Wednesday, May 3rd, 2023
- David Hoang of "SMBC Nikko" Initiated at Buy and Held Target at $80 on, Wednesday, April 26th, 2023
- Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $60 on, Friday, February 10th, 2023
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $90 on, Friday, February 10th, 2023
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $55 on, Wednesday, February 8th, 2023
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $52 on, Tuesday, February 7th, 2023
- Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $58 on, Tuesday, February 7th, 2023
Contributing Sources